Review
Open access
Sep 2026
Structural Foundation of CTLA-4 antibodies: Emerging Platforms for Next-generation Cancer Immunotherapy.
By connecting atomic-level receptor recognition to clinical outcome, this review provides a mechanistic foundation for the rational design of next-generation CTLA-4 therapeutics with improved efficacy and reduced immune-related toxicity.
Enat Mengistu Leta, S. Syed, Geleta Negasa Binegde et al.
· International Immunopharmaco... · 0 citations